Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Archives

You are currently viewing the 2002 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: chloroquine phosphate

« Back to Dashboard
Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms Llc, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Teva, and Watson Labs, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for chloroquine phosphate.

Summary for Generic Name: chloroquine phosphate

Tradenames:3
Patents:0
Applicants:7
NDAs:9
Drug Master File Entries: see list17
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Clinical Trials for: chloroquine phosphate

Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Status: Recruiting Condition: Carcinoma, Intraductal, Noninfiltrating; DCIS; Ductal Carcinoma In Situ

Chloroquine Population Pharmacokinetics in Pre and Post-partum Women
Status: Recruiting Condition: Vivax Malaria

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Purepac Pharm
CHLOROQUINE PHOSPHATE
chloroquine phosphate
Tablet; Oral080886-001Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Sanofi Synthelabo
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE
chloroquine phosphate; primaquine phosphate
Tablet; Oral014860-002Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Impax Labs
CHLOROQUINE PHOSPHATE
chloroquine phosphate
Tablet; Oral080880-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Teva
CHLOROQUINE PHOSPHATE
chloroquine phosphate
Tablet; Oral087504-001JAN 13, 1982DISCNNo<disabled><disabled>
Sanofi Synthelabo
ARALEN
chloroquine phosphate
Tablet; Oral006002-001Approved prior to Jan 1, 1982RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc